T he latest research results regarding the human genome open the possibility of suggesting an optimal therapy for each individual on the basis of knowledge of the patient's genotype (12) . Many genes whose mutations cause inborn single-gene diseases or cancer have been described in detail. More importantly, additional genes involved in multigenic diseases have been identified. However, it is a particular combination of their alleles that increases the risk and modifies the outcome and efficiency of therapy (2) .
It is generally difficult to study these genes. The reasons are in their multiplicity, high number of mutual combinations of their alleles, low penetrance, and extrafamilial occurrence of the diseases. Recombinant congenic strains (RCS) of mice are a very efficient genetic tool, allowing the genetic dissection of genes involved in a complex trait (6) . Another possibility, recombinant inbred strains (a cross between two inbred strains of mice) is the most used model to study complex traits. However, recombinant inbred strains are more effective for mapping the genes with stronger penetrance. (Various models are reviewed in Refs. 2, 4, and 7.) Because of the high homology between human and mouse genome, it is possible to expect that the same gene will relate to the same disease in humans and mice; however, the particular polymorphism can be different.
Identification of those genes modifying risk for and course of a disease could lead to an explanation of molecular mechanisms and to detection of new targets for therapy. Although the initial aim of such research is not prevention, it is also possible to assess risk factors for a disease in a healthy person by knowing his/her genotype.
Since cancer is probably the most investigated disease and it perfectly illustrates a complex trait, we will explain the principles of genetic analysis of this trait using RCS. After that, a short review of results obtained so far will be given.
Cancer and related genes
Cancer is caused by sequential mutations in one cell, which give this cell and its clones selective advantages such as fast and unregulated division, ability to induce vascularization, or ability to invade other tissue (13) . Mutations causing cancer mainly affect well-known protooncogenes and tumor suppressor genes participating in regulation of cell division. In the development of this disease, a large number of nonmutated genes also play a role (1). They can influence the susceptibility to cancer after carcinogen exposition, tumor number and size, the rate of tumor growth, the site of tumor formation, histological type, and progress toward malignancy (6) . These genes are called tumor susceptibility genes (6) or tumor modifier genes (TMGs) (2) . Similarly, the alleles are called susceptible or resistant, depending on whether they support or inhibit tumorigenesis. Besides carcinogen metabolism, TMGs are associated with tissue's ability to grow, to invade, to differentiate, to induce appropriate vasculature, to stimulate an immune response, to control genome stability, or to repair damaged DNA. All of them obviously can be critical to tumor progression (2) .
With respect to complexity of the disease, the influence of both single gene effects as well as gene interactions can be expected. It even appears that gene interactions are much more frequent than predicted. The high frequency of these interactions suggests the existence of synergic pathways and molecular interactions (e.g., protein-protein interactions) as well as the existence of complex interactions (23) . Except for reciprocal interactions, or epistasis, counteracting interactions are very common. In the case where two loci are involved in counteracting interaction, their alleles confer either susceptibility or resistance depending on a specific genetic combination. The same allele can have opposite effects in a different background. The opposite effects of the same allele in combination with the partner locus allele mask each other. Consequently, in spite of the relatively large effects of these loci together, there is no effect if each of them is considered alone. At present, this type of interaction has been detected in many loci and with many biological traits (24) .
Originally, it was suggested that most TMGs influence the cellular processes related to neoplastic development, rather than systemic factors (6) . However, as the number of identified candidate loci increased, it was found that their chromosomal positions overlap less randomly than expected. This implies that multiple TMGs influence several types of cancer by functioning systematically or by functioning in one type of tissue present in different organs, e.g., in the epithelial tissue of the lung and of the colon (9) .
The most difficult problems with mapping TMGs are their low penetrance, phenotypic variability due to the influence of environment, and especially their complex interactions. Frequently, the individual alleles are not intrinsically susceptible or resistant, but their effect is influenced by the genotype at the interacting locus. Since every individual has a unique combination of alleles of TMGs, we could not resolve their interactions and effect without decreasing genetic variability. For that reason, we cannot use any method of genetic mapping such as linkage analysis in affected families, allele-sharing methods, or association studies in human populations. We have to use the fourth method: animal crosses.
The most suitable model is a mouse, because it is possible to cross it to obtain a high number of individuals with a defined genome. The entire experimental group can be bred under identical conditions to eliminate environmental influence on phenotype, and, conveniently, mice have a short generation period.
RCS
The RCS can be used to analyze molecular mechanisms of any biological process, such as atherosclerosis or infectious and metabolic diseases, especially those complex traits for which the two parental strains differ (19) . Recently, many new series of RCS have been founded especially to study particular complex traits (11, 15) .
RCS were first developed in the Netherlands, and they were designed to analyze specifically the traits under multigenic control (8) . RCS were created by crossing two inbred strains that strongly differ in reaction to transplacental carcinogen treatment. The former, e.g., strain A, is susceptible because it develops many large tumors with malignant appearance. The latter, strain B, develops few small tumors, and that is why it is called resistant. F1 mice were backcrossed to strain A, and the N1 generation was also backcrossed to strain A. Mice from the following generation had 12.5% of their genome from parent B (donor strain) and the remaining 87.5% of the genome from parent A (background strain). On average, 20 litters were randomly selected, and brother-sister mating over 20 generations followed, so that all genes were in a homozygous state. In this way, a series of 20 inbred strains were founded, each carrying a different random subset of ~12.5% genes from the donor strain and the remaining 87.5% genes from the background strain. In other words, genome of the donor strain was dissected in 20 RCS in 12.5% parts and that part is different in each of 20 RCS (Fig. 1) . Genes of a multigenic trait were also dissected into oligo or single-gene traits (6, 19) .
The only weakness of the RCS model is paradoxically connected with its greatest advantage: the very decreased genetic variability. In fact, each set of RCS is derived from two parental strains, and therefore the study is limited to only two alleles of a gene. The candidate allele may also have significant effect in one genetic background but none in another. However, because TMG mapping in humans is difficult and TMGs are still virtually unknown to date, their identification on the basis of murine TMGs is of crucial importance (6).
Mapping with RCS
The first step of course is to identify which RCS inherited the part of the donor's genome where TMGs are. For example, when studying TMGs of lung cancer, RCS as well as parent strains have to undergo transplacental carcinogen treatment. The resulting phenotype is determined by histological analysis of tumor tissue.
More specifically, RCS OcB/Dem are used to study lung cancer. The background susceptible strain is O20/A (O20), and the resistant donor strain is B10.O20/Dem (B10.O20). O20 develops higher number of larger tumors than B10.O20. Moreover, the O20 tumors are mainly of the solid, alveolar type with frequent secondary papillary structures in the central part. Nuclear pleiomorphy may be very extensive, and lymphocyte infiltration is found rather frequently, in contrast to the B10.O20 tumors. B10.O20 mice develop almost exclusively papillary adenomas with homogenous populations of tumor cells with no nuclear pleiomorphy. The majority of the 20 OcB/Dem strains develop tumors, which are for a greater part similar to those of the O20 strain, except two of them, OcB-4 and OcB-6. In strain OcB-4, about half of the lung tumors are of alveolar type without secondary papillary structures and they exhibit little or no nuclear plesiomorphism. Tumors in the strain OcB-6 are pre- http://physiologyonline.physiology.org/ dominantly papillary, including the periphery of tumor, in this respect resembling the strain B10.O20; but in contrast to this parent, they have considerable nuclear pleiomorphy (9) . Histological appearance of tumors of different strains is summarized in Table 1 .
There are so many genes involved in tumorigenesis that one cannot assign the individual effect of each gene to a phenotype absolutely. Since parent strains serve as reference values, phenotype variance is also decreased in RCS. Therefore, due to parental strain we are able to recognize when an active allele is replaced with a nonactive one or when an interaction arises or perishes.
After phenotyping, genotyping allows us to find which part of the donor genome is in which OcB/Dem strain. Variable numbers of tandem repeats (called markers) are used. Individual alleles can be differentiated by PCR followed by agarose gel electrophoresis for determination of fragment length. Besides these molecular markers, the strains were typed for a number of biochemical, serological, and restriction fragment length polymorphisms. The typing data for individual RCS are deposited in the Mouse Genome Database at The Jackson Laboratory that serves as a comprehensive resource available online (http://www.informatics.jax.org). For example, RCS OcB/Dem have already been typed for 611 markers (19) .
With the methods described briefly above, it is possible to select an individual strain from RCS, which differs from parent strains, and to determine which part of the donor genome it inherited and that this part is responsible for the phenotype difference. How to find then the particular gene in this region? The methods are again phenotyping and genotyping. Obviously, we cannot use the homozygous RCS; we have to generate different genotypes in loci of donor origin. Therefore, we have to cross this strain with a background strain to obtain the F2 generation.
The major advantage of RCS is that only ~12.5% of the genome segregates in a cross between RCS and its parental background strain, in contrast with crosses in which the whole genome is segregating. The effect on phenotype of each marker, sex, and interactions between pairs are tested by analysis of variance. The ultimate aim of this analysis is to find a marker whose one parent allele is connected with a certain tumor feature while the allele of the second parent origin is not (or even causes an opposite effect). Of course, the marker is not responsible for the phenotype difference. It is a gene and its alleles located close to that marker. Then this candidate locus is shortened as much as possible by detailed mapping and submitted to positional cloning.
Major achievements obtained by using RCS
So far, two candidate genes have been identified with RCS. The first is the combined hyperlipidemia gene Hyplip 1, and the second is Ptprj (receptor-type protein tyrosine phosphatase), a candidate gene for the colon cancer susceptibility locus Scc1.
Familial combined hyperlipidemia represents the most common genetic dyslipidemia, with a prevalence of 1.0 2.0%. HcB-19, a strain from RCS HcB/Dem, also has symptoms of this disease, although parent strains are normal. This finding suggests the development of spontaneous mutation de novo. After fine mapping and positional cloning, the sequencing diagnosed the presence of a nonsense mutation in gene called Hyplip 1. It codes Txnip (thioredoxin-interacting protein). Txnip binds reduced thioredoxin, a major regulator of cellular redox state, and inhibits its reducing activity. It is suggested that altered redox status downregulates the citric acid cycle, sparing fatty acids for triglyceride and ketone body production, major symptoms of combined hyperlipidemia. This is a new pathway of plasma lipid metabolism with potential clinical significance (3).
Ptprj was identified by positional cloning. It encodes a receptor-type protein tyrosine phosphatase. The coding sequences of resistant and susceptible alleles show 16 singlenucleotide differences. Furthermore, frequent deletions of Prptj, allelic imbalance in loss of heterozygosity, and missense mutations occur in human colon, lung, and breast cancer (16) .
Recently, Czarnomska et al. (5) confirmed that a host genome influences a number of intestinal and mammary tumors as well as the histological type of mammary tumors. Furthermore, they found that susceptibility to both types of cancer had opposite distribution within RCS. The strains most susceptible to intestinal tumor were the most resistant to mammary tumors and vice versa. They used OcB/Dem mice carrying multiple intestinal neoplasia (Min) mutation in the adenomatous polyposis coli (Apc) gene. Other important results are summarized in Table 2 .
Conclusions
The RCS are a very efficient tool capable of genetic dissection of complex traits and even of identification of gene interactions. The results from lung cancer research on RCS have shown that one locus can be found by testing ~29 F2 mice and one interaction per 35 F2 mice (23) . Mapping on RCS is very sensitive; it is not rare for a susceptible allele to be found in a resistant strain and vice versa (24). The reliability of identification of responsible genes in RCS mapping increases when the same candidate locus is present in more than one strain. In addition, the candidate locus can be further shortened: the recombinant event can occur in a different locus in each strain, but the candidate loci are present only in a segment from the donor parent.
One can expect that the importance of RCS will significantly increase in future. So far, mostly quantitative traits (e.g., size and number of tumors) have been analyzed. However, quantitative aspects (e.g., tumor type, localization) might prove to be of even more importance. Tripodis and Demant (22) and Czarnomska et al. (5) have already published the first studies about qualitative traits.
Identification of all genes involved in the progression of a disease and especially their functions will enable us to understand the molecular mechanisms of these processes and to discover new targets for therapy. This progress will be the basis for future individualized treatment and prevention based on knowledge of a patient's genotype and for reliable prognosis when the most efficient way of therapy can be determined. Although infectious disease is initially dependent on random meeting pathogen and not on inherited dispositions of an individual, the course of the developing disease can be strongly influenced by interactions between host and pathogen genome. For genetic analysis of susceptibility to infectious diseases, the mouse models are especially suitable because they allow not only control of environmental factors such as pathogen status, dose, and route of infection but also enable generation of crosses between any individuals (10). To dissect immune response to pathogen in vivo, Leishmania major infection was analyzed (24) . d Idd13 contains at least two genes: E 2 -microglobulin is a candidate gene (17) . The importance of these RCS is their new way of being constructed. Some strains were produced by interval-specific selection as inbreeding of these lines progressed. The mice were selectively bred to fix diabetogenic or nondiabetogenic alleles into different RCS. As a result, the RCS allow testing of interactions predicted by previous crosses (15) .
